|
BAG5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.12420122894741E-11 |
| Normal-vs-Stage2 |
4.65671945448776E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62581059726108E-12 |
| Stage1-vs-Stage2 |
8.104100E-03 |
| Stage1-vs-Stage3 |
7.91230000000143E-05 |
| Stage1-vs-Stage4 |
1.030690E-04 |
| Stage2-vs-Stage3 |
7.805800E-01 |
| Stage2-vs-Stage4 |
5.268600E-01 |
| Stage3-vs-Stage4 |
6.424400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.69850000017757E-07 |
| Normal-vs-Asian |
5.197200E-03 |
| Caucasian-vs-AfricanAmerican |
1.904820E-01 |
| Caucasian-vs-Asian |
7.411800E-01 |
| AfricanAmerican-vs-Asian |
8.597800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.79759565408244E-11 |
| Male-vs-Female |
5.883600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.06379999978523E-07 |
| Normal-vs-Age(41-60Yrs) |
1.63469238145808E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(81-100Yrs) |
2.33839999996821E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.850000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.582200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.993800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.160800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.068000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.751000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.773800E-02 |
| Normal-vs-Grade 2 |
3.3559000023331E-10 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.708350E-01 |
| Grade 1-vs-Grade 3 |
2.297300E-03 |
| Grade 1-vs-Grade 4 |
3.410600E-04 |
| Grade 2-vs-Grade 3 |
2.28289999999465E-05 |
| Grade 2-vs-Grade 4 |
2.93350000002413E-06 |
| Grade 3-vs-Grade 4 |
8.799900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.55371287952266E-12 |
| Normal-vs-ccB subtype |
1.79467551930657E-12 |
| ccA subtype-vs-ccB subtype |
8.469800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.626032641866E-12 |
| Normal-vs-N1 |
6.1035999587844E-09 |
| N0-vs-N1 |
3.102000E-02 |
|
|
